Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CODEXIS, INC. Director's Dealing 2010

Aug 11, 2010

33607_dirs_2010-08-11_ade9b69a-7637-4e31-bf73-d3c531abfe68.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CODEXIS INC (CDXS)
CIK: 0001200375
Period of Report: 2010-08-10

Reporting Person: Sarret Joseph J. (CBO, President Pharmaceuticals)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-08-10 Common Stock P 2000 $7.989 Acquired 2000 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 13333 Indirect

Footnotes

F1: Shares held by Joseph Sarret as Trustee UTD 5/30/00.